Supportive Program for Mother With BPD (PAM-B)

July 28, 2014 updated by: University Hospital, Toulouse

Effect on Relationship of a Brief Preventive Program: Pragmatic Pilot Randomized Controlled Trial." - Supportive Program for Mother With BPD

Borderline Personality Disorder (BPD) is characterized by a pervasive pattern of instability of interpersonal relationships, self-image and emotions as well as marked impulsivity. When patients have children, they are at high risk of severe emotional and relational disturbances (withdrawal, low self-esteem, depression, suicidal thoughts). In addition, studies support the effectiveness of parental guidance group to reduce emotional and behavioral difficulties of children. To our knowledge there are no programs directed to mothers with BPD who received a controlled evaluation.

From experience with parental guidance, data from the observation of children of patients with BPD and psychosocial programs directed to patients BPD, we have built for preventive intervention. The Supportive Program for Mothers with BPD (SuPMother-B) consists of 10 group sessions providing information (education, childcare, care specific to BPD) and promotes mother-child interactions (observation, games).

Purpose: Compare the effect of a program (SuPMother-B) group, of 10 sessions, offered to mothers with a BPD in addition to a minimal intervention (diagnostic announcement and provision of health care resources) on behavior withdrawal of children at 6 months compared to a group of mothers receiving only minimal intervention.

Primary outcome: Difference at 6 months between the experimental and control groups on scores on the assessment scale withdrawal (Alarm Distress Baby (ADBB)).

Study Overview

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Toulouse, France, 31059
        • Service de psychiatrie de l'enfant et de l'adolescent - Hôpital La Grave - centre Hospitalier de Toulouse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Mother:

  • Women with children and at least one child aged 2 months to 2 years, Borderline Personality Disorder with SIDP (Structured Interview for DSM Personality Disorders)
  • age above 18 years
  • written consent

Child:

  • ages between 2 months and 2 years,
  • parental consent for research participation.

Exclusion Criteria:

Mother:

  • chronic psychotic disorder, major depressive disorder, current mania or hypomania,
  • legal protection,
  • if no child can be included, the mother cannot be included.

Child :

•major psychomotor development disorder or psychiatric disorder according to the investigator.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: BPD prevention
Supportive Program for Mother with BPD (SuPMother-B) : BPD mothers participate to prevention program in groups or/and house calls.

The development of the program is based on several principles: group process, groupware, mentalization, parental values, behavioral strategies and information on the child's needs, knowledge of the BPD and the strategies of get better. The program will last 10 sessions of group of about 2h.

Minimal intervention. All study participants receive an individual interview about 45 minutes with a psychiatrist for three objectives: information on the diagnosis of BPD, information on resources for health care and educational aids.

No Intervention: Usual care of BPD mothers
BPD mothers don't participate to Supportive Program (SuPMother-B).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Difference between the experimental and control groups on scores on the assessment scale withdrawal (Alarm Distress Baby (ADBB)).
Time Frame: Visit 3 at 6 months
Visit 3 at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brunet-Lezine Scale
Time Frame: Visit 2 (inclusion), 3 (6 months) and 4 (1 year)
This scale permits to assess the psychomotor development of the child.
Visit 2 (inclusion), 3 (6 months) and 4 (1 year)
Borderline Personality Disorder Severity Index (BPDSI)
Time Frame: Visit 2 (inclusion), 3 (6 months) and 4 (1 year)
Borderline Personality Disorder Severity Index (BPDSI) is a semi-structured interview assessing the frequency and severity of manifestations of borderline personality disorders of the mother during an agreed period (3 months to 1 year).
Visit 2 (inclusion), 3 (6 months) and 4 (1 year)
Global Assessment Scale
Time Frame: Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 Year)
This scale corresponds to the 5th axis of the Diagnostic and Statistical Manual of Mental Disorders (DSM) and permits to assess the overall functioning of the mother.
Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 Year)
Difference between the experimental and control groups on scores on the assessment scale withdrawal (Alarm Distress Baby (ADBB)).
Time Frame: Visit 2 (inclusion) and visit 4 (1 Year)
Visit 2 (inclusion) and visit 4 (1 Year)
M.I.N.I. 5.0.0 French version
Time Frame: Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year)
Structured interview to assess 17 disorders such as actual or passed depression, mania, abuse...
Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year)
Parenting Sense of Competence Scale (P.S.O.C)
Time Frame: Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year)
This scale assess the perceived competence of the parent's role as educator.
Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year)
social and demographic data
Time Frame: Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year)
marital status, profession, socio-economic level, number of children
Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year)
Data on care pathways
Time Frame: Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year)
Questionnaire established by the research team to evaluate the use of care services by the mothers and children.
Visit 2 (inclusion), Visit 3 (6 months), Visit 4 (1 year)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: CHEYNIER, UTAMS PMI Empalot
  • Principal Investigator: LATOUR, UTAMS PMI Reynerie
  • Principal Investigator: BLEY-RIBET, UTAMS PMI Bonnefoy
  • Principal Investigator: MULQUIN, UTAMS PMI Rangueil
  • Principal Investigator: KOUBAA, UTAMS PMI Cazères
  • Principal Investigator: BERTIN, UTAMS PMI Montauban

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

July 1, 2014

Study Registration Dates

First Submitted

January 22, 2013

First Submitted That Met QC Criteria

July 28, 2014

First Posted (Estimate)

July 30, 2014

Study Record Updates

Last Update Posted (Estimate)

July 30, 2014

Last Update Submitted That Met QC Criteria

July 28, 2014

Last Verified

July 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 11 199 08
  • Interregional PHRC 2011 (Other Grant/Funding Number: French Ministry of Health)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder

3
Subscribe